Demystifying menopausal hormone therapy prescribing
BACKGROUND: Menopause and perimenopause are associated with vasomotor symptoms and other symptoms that can affect quality of life. Menopausal hormone therapy (MHT) improves menopausal symptoms and reduces the risk of osteoporosis and fracture. OBJECTIVE: This article provides an updated overview of the basic principles of prescribing MHT, including the risks and benefits and practical information for tailoring treatment to the individual. DISCUSSION: Women presenting at menopause should have a comprehensive assessment including updated health screening and promotion of a healthy lifestyle. MHT can be offered to women with symptoms in the absence of contraindications, following a discussion about risks and benefits. MHT comprises systemic oestrogen, and for those with an intact uterus, a progestogen.
Authors
- Christina Jang
- Karen Magraith
Institutions
- University of Tasmania (AU)
- The University of Queensland (AU)
Publication Details
- Journal
- Australian Journal of General Practice
- Published
- 2026-04-01
- DOI
- https://doi.org/10.31128/ajgp-12-25-7923
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00